Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis.

Batsuli, Glaivy; Zimowski, Karen L; Tickle, Kelly; Meeks, Shannon L; Sidonio, Robert F

Batsuli, Glaivy; Zimowski, Karen L; Tickle, Kelly; Meeks, Shannon L; Sidonio, Robert F.

Affiliation

Batsuli G; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, Georgia.
Zimowski KL; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, Georgia.
Tickle K; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia.
Meeks SL; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, Georgia.
Sidonio RF; Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, Georgia.

Haemophilia ; 25(5): 789-796, 2019 Sep.

Article in En | MEDLINE | ID: mdl-31373431

Subject(s)

Antibodies, Bispecific/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Hemophilia A/drug therapy; Immune Tolerance/drug effects; Antibodies, Bispecific/pharmacology; Antibodies, Monoclonal, Humanized/pharmacology; Child; Child, Preschool; Female; Humans; Male; Retrospective Studies

Key words

bypassing agents; emicizumab; haemophilia A; immune tolerance; inhibitors; paediatrics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Antibodies, Monoclonal, Humanized / Hemophilia A / Immune Tolerance Type of study: Guideline / Observational_studies Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2019 Type: Article Affiliation country: Georgia

Fulltext

XML

PubMed Links

Search on Google